Skip to search formSkip to main contentSkip to account menu

Bone Marrow Neoplasms

Known as: bone cancer marrow, Bone Marrow Neoplasms [Disease/Finding], Bone Marrow Tumor 
Neoplasms that affect the bone marrow. Such neoplasms may arise in the bone marrow (e.g. myeloid leukemias) or may involve the bone marrow as… 
National Institutes of Health

Related topics

Related topics

19 relations
Blood supply aspectsBone MarrowHuman herpesvirus 3In Blood

Broader (2)

Bone Marrow Diseasesmedulla (exluding hematopoietic marrow reactions)

Narrower (2)

Myeloproliferative diseasemalignant neoplasm of bone marrow

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
Human prostate cancer frequently metastasizes to bone marrow. What defines the cellular and molecular predilection for prostate… 
Highly Cited
2007
Highly Cited
2007
Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients
Purpose: Micrometastatic cells detected in the bone marrow have prognostic significance in breast cancer. These cells are… 
Highly Cited
2006
Highly Cited
2006
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.
Insulin-like growth factor 1 (IGF-1) plays a pleiotropic role in multiple myeloma (MM), that is, in survival, proliferation… 
Highly Cited
2005
Highly Cited
2005
Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.
To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified… 
Highly Cited
2004
Highly Cited
2004
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
PURPOSE Iodine-131-metaiodobenzylguanidine ((131)I-MIBG) has been shown to be active against refractory neuroblastoma. The… 
Highly Cited
1999
Highly Cited
1999
Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor.
Highly Cited
1997
Highly Cited
1997
Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.
Highly Cited
1996
Highly Cited
1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.
Mutations of members of the ras family are among the most common oncogene mutations found in multiple myeloma (MM). We have… 
Highly Cited
1996
Highly Cited
1996
Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
BACKGROUND Approximately half of the patients diagnosed with localized esophageal cancer die of metastatic disease within the… 
Highly Cited
1996
Highly Cited
1996
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.
The blood of most patients with active multiple myeloma (MM) contains cells related to the bone marrow tumor. However… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)